Clinical Trial Update: The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast Cancers [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial called EMPOwER is evaluating multiparameter gene testing as a predictor of short-term endocrine therapy response in hormone receptor-po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN